[1]
J. Del Rosso, “Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient PASI and PASI-HD Responses: Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials”, J of Skin, vol. 8, no. 2, p. s355, Mar. 2024.